| JPM THEMATICS-GENETIC THERAPIES C2 (DIST) CHF (HEDGED) | RVI BIOTECNOLOGÍA | 40,52% | 13,96% | -22,73% | · |
| AVIVA INVESTORS - GLOBAL EMERGING MARKETS INDEX I USD | RVI EMERGENTES | 40,51% | 69,66% | 43,86% | 126,45% |
| CANDRIAM EQUITIES L ROBOTICS & INNOVATIVE TECHNOLOGY C-H CAP EUR | RVI TECNOLOGÍA | 40,51% | 75,73% | 61,05% | · |
| COMGEST GROWTH JAPAN USD I ACC | RVI JAPÓN CRECIMIENTO | 40,51% | 55,08% | 20,45% | · |
| FIDELITY FUNDS-JAPAN GROWTH Y-ACC-EUR (HEDGED) | RVI JAPÓN | 40,51% | 73,30% | 81,16% | 225,95% |
| GOLDMAN SACHS EMERGING MARKETS EQUITY PORTFOLIO OTHER CURRENCY EUR CAP | RVI EMERGENTES | 40,50% | 64,28% | 17,70% | 116,93% |
| MFS MERIDIAN ASIA EX-JAPAN FUND A1-EUR | RVI ASIA EX-JAPÓN | 40,50% | 58,47% | 28,44% | 106,10% |
| AXA IM GLOBAL EMERGING MARKETS EQUITY QI A EUR ACC | RVI EMERGENTES | 40,49% | 88,15% | 68,00% | 160,41% |
| FIDELITY FUNDS-ASIA EQUITY ESG A-ACC-USD | RVI ASIA EX-JAPÓN | 40,49% | 47,23% | 23,62% | 127,89% |
| POLAR CAPITAL ASIAN STARS R USD CAP | RVI ASIA PACÍFICO | 40,49% | 64,68% | 34,73% | · |
